Beam Therapeutics (BEAM) Metrics: History & Chart

Beam Therapeutics Inc.(BEAM)

Biotechnology · Cambridge, MA

$24.47+0.08 (+0.33%)

Delayed quote: Oct 2, 2026, 3:55 PM EDT

About Beam Therapeutics Inc.

Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta thalassemia. BEAM-102 is specifically designed for addressing sickle cell disease. BEAM-201, an allogeneic chimeric antigen receptor T-cell therapy, is under investigation for individuals suffering from relapsed or refractory T-cell acute lymphoblastic leukemia. BEAM-301 is a liver-targeted candidate aimed at patients afflicted with Glycogen Storage Disease Type Ia. Beyond these flagship programs, Beam Therapeutics is also engaged in devising treatments for alpha-1 antitrypsin deficiency, various ocular conditions, and other disorders impacting the liver, muscular system, and central nervous system. To further its research and development objectives, Beam Therapeutics has forged numerous strategic alliances and partnerships. These include collaborations with Boston Children's Hospital; a research and clinical trial agreement with Magenta Therapeutics, Inc.; a licensing deal with Sana Biotechnology, Inc.; and a research partnership with the Institute of Molecular and Clinical Ophthalmology Basel. Additionally, the company maintains research collaborations with both Pfizer Inc. and Apellis Pharmaceuticals, Inc., alongside a comprehensive collaboration and license agreement with Verve Therapeutics, Inc.

Cambridge, MA

540 employees

www.beamtx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: John Evans

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-1.09%
30D Total Return	-15.95%
YTD Total Return	-12.01%
1Y Total Return	+1.08%
3Y Total Return	+1.42%
5Y Total Return	-71.77%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-12.01%
2025	+11.77%
2024	-8.89%
2023	-30.40%
2022	-50.92%
2021	-2.39%
2020

CAGR TTM	+1.08%
CAGR 3Y	+0.47%
CAGR 5Y	-22.35%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

BEAM Valuation Metrics

BEAM Stock Price Metrics

BEAM Dividend Metrics

BEAM Growth Rate Metrics

BEAM Discounted Cash Flow Metrics

BEAM Returns By Period

BEAM Yearly Returns

BEAM Average Annual Returns By Period (CAGR)

BEAM Revenue Metrics

BEAM PE Ratio Metrics

BEAM PS Ratio Metrics

BEAM PB Ratio Metrics

BEAM Price to Free Cash Flow Ratio Metrics

BEAM Debt to Equity Ratio Metrics

BEAM PEG Ratio Metrics

BEAM FCF Yield

BEAM Earnings Yield

BEAM EBITDA Yield

BEAM OCF Yield

BEAM EV/EBIT Ratio Metrics

BEAM EV/EBITDA Ratio Metrics

BEAM EV/Assets Ratio Metrics

BEAM EV/Sales Ratio Metrics

BEAM Current Ratio Metrics

BEAM Quick Ratio Metrics

BEAM ROIC Metrics

BEAM Return on Assets Metrics

BEAM Return on Equity Metrics

BEAM Net Profit Margin Metrics

BEAM Gross Profit Margin Metrics

BEAM Tax Rate Metrics

PS Ratio	16.31
PS Ratio Avg TTM	30.85
PS Ratio Avg 3Y	21.15
Current VS TTM Avg	-47.13%
Current VS 3Y Avg	-22.90%
Current VS 5Y Avg	-41.60%

PB Ratio	2.38
PB Ratio Avg TTM	2.64
PB Ratio Avg 3Y	2.44
Current VS TTM Avg	-9.89%
Current VS 3Y Avg	-2.57%
Current VS 5Y Avg	-18.68%

PFCF Ratio	71.68
PFCF Ratio Avg TTM	44.80
PFCF Ratio Avg 3Y	44.80
Current VS TTM Avg	+59.99%
Current VS 3Y Avg	+59.99%
Current VS 5Y Avg	+59.99%

Debt/Equity Ratio	0.23
Debt/Equity Ratio Avg TTM	0.20
Debt/Equity Ratio Avg 3Y	0.20
Current VS TTM Avg	+17.14%
Current VS 3Y Avg	+18.33%
Current VS 5Y Avg	+13.74%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.40%
FCF Yield Avg TTM	3.15%
FCF Yield Avg 3Y	3.15%
Current VS TTM Avg	-55.58%
Current VS 3Y Avg	-55.58%
Current VS 5Y Avg	-55.58%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.86
Ev/Assets Ratio Avg TTM	2.00
Ev/Assets Ratio Avg 3Y	1.65
Current VS TTM Avg	-7.21%
Current VS 3Y Avg	+12.59%
Current VS 5Y Avg	+4.07%

Ev/Sales Ratio	16.48
Ev/Sales Ratio Avg TTM	29.99
Ev/Sales Ratio Avg 3Y	20.03
Current VS TTM Avg	-45.05%
Current VS 3Y Avg	-17.73%
Current VS 5Y Avg	-38.79%

Current Ratio	14.57
Current Ratio Avg TTM	11.48
Current Ratio Avg 3Y	6.62
Current VS TTM Avg	+26.89%
Current VS 3Y Avg	+120.14%
Current VS 5Y Avg	+156.35%

Quick Ratio	14.57
Quick Ratio Avg TTM	11.48
Quick Ratio Avg 3Y	6.62
Current VS TTM Avg	+26.89%
Current VS 3Y Avg	+120.14%
Current VS 5Y Avg	+156.35%

ROIC	(28.96%)
ROIC Avg 3Y	(28.74%)
ROIC Avg 5Y	(29.54%)
Current VS 3Y Avg	-0.74%
Current VS 5Y Avg	+1.99%
Current VS 10Y Avg	+10.40%

ROA	(6.16%)
ROA Avg TTM	(2.94%)
ROA Avg 3Y	(7.55%)
Current VS TTM Avg	-109.87%
Current VS 3Y Avg	+18.45%
Current VS 5Y Avg	+7.48%

ROE	(8.00%)
ROE Avg TTM	(20.21%)
ROE Avg 3Y	(25.43%)
Current VS TTM Avg	+60.41%
Current VS 3Y Avg	+68.54%
Current VS 5Y Avg	+75.29%

Net Profit Margin	(54.75%)
Net Profit Margin Avg TTM	(5498.01%)
Net Profit Margin Avg 3Y	(660.39%)
Current VS TTM Avg	+99.00%
Current VS 3Y Avg	+91.71%
Current VS 5Y Avg	+90.69%

Gross Profit Margin	84.05%
Gross Pft Margin Avg TTM	(374.73%)
Gross Pft Margin Avg 3Y	(491.53%)
Current VS TTM Avg	+122.43%
Current VS 3Y Avg	+117.10%
Current VS 5Y Avg	+119.28%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.47%
Tax Rate Avg 5Y	0.47%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%